UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 28, 2003
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
---------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
----------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
------------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
----------------
(Registrant's telephone number, including area code)
1
Item 7. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated October 28, 2003
Item 9. Regulation FD Disclosure.
The Company announced that it will report its third quarter 2003 results for the
period ended September 27, 2003 before the market opens on Thursday, November 6,
2003. Ultralife management will host an investor conference call at 10:00AM ET
also on November 6, 2003. Investors are invited to access a live webcast of the
conference call at http://www.ultralifebatteries.com/invest.asp. A replay of the
webcast will be available shortly after the call at the same location and will
be archived for 90 days. Refer to the attached Exhibit 99.1 for the entire test
of the release, which Exhibit is being furnished but not filed in accordance
with Regulation FD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: October 28, 2003 By: /s/ Robert W. Fishback
----------------------
Robert W. Fishback
Vice President of Finance &
Chief Financial Officer
2
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated October 28, 2003
3
Exhibit 99.1
Ultralife Batteries Inc. to Report
Third Quarter Results on November 6, 2003
NEWARK, N.Y.--(BUSINESS WIRE)--Oct. 28, 2003--
Investor Conference Call to be Webcast at Ultralife Batteries' Web
Site
Ultralife Batteries, Inc. (NASDAQ: ULBI) will report its third
quarter 2003 results for the period ended September 27, 2003 before
the market opens on Thursday, November 6, 2003. Ultralife management
will host an investor conference call at 10:00AM ET also on November
6, 2003. Investors are invited to access a live webcast of the
conference call at http://www.ultralifebatteries.com/invest.asp. A
replay of the webcast will be available shortly after the call at the
same location and will be archived for 90 days.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of
standard and customized lithium primary (non-rechargeable), lithium
ion and lithium polymer rechargeable batteries. Ultralife's
high-energy batteries use advanced lithium technology and are used in
military, industrial and consumer portable electronic products.
Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next
generation of battery solutions. OEM, retail and government customers
include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack
and the national defense agencies of the United States and United
Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing and research facility, is located in
Abingdon, U.K. Both facilities are ISO-9001/2000 certified.
Detailed information on Ultralife is available at the Company's
web site, www.ultralifebatteries.com.
CONTACT: Company:
Ultralife Batteries, Inc.
Robert W. Fishback, 315-332-7100
bfishback@ulbi.com
or
Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jks@lhai.com
or
Media Contact:
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com